Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company announced today that its LEGION Hinged Knee (HK) ...

Smith+Nephew (NYSE: SNN) announced today that it launched its Legion hinged knee (HK) system with Oxinium implant technology ...

The U.S. Food and Drug Administration (FDA) has granted 510 (k) clearance for the combined use of two surgical planning and ...

Every year in Australia, more than 50,000 hip replacements are performed. In the United States, this number is more than ...

First cases using Smith+Nephew’s new CATALYSTEM™ Primary Hip System completed; surgeons hail precision, efficiency and reproducibility GlobeNewswire September 18, 2024 Smith+Nephew (LSE:SN, NYSE:SNN), ...

Smith+Nephew (LSE:SN, NYSE ... Designed to address the evolving demands of primary hip surgery - including the increased adoption of anterior approach procedures – the CATALYSTEM Primary Hip ...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology ... Designed to address the evolving demands of primary hip surgery – including the increased adoption of anterior approach procedures – ...

Addtionally, some of the LEGION prostheses are available for use with our VISIONAIRE, patient matched cutting blocks for knee surgery.

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company announced today that its LEGION Hinged Knee (HK) System is now available in the United States with proprietary OXINIUM (Oxidized ...

He has previously had surgery on his right hip, right knee, and lower back. In its campaign, Smith+Nephew is highlighting its Regeneten Bioinductive Implant used to repair rotator cuff injuries ...